TY  - JOUR
AU  - Valencia, Inés
AU  - Pastor-Martínez, Andrea
AU  - Decouty-Pérez, Céline
AU  - Lopez-Rodriguez, Ana Belen
AU  - Álvarez-Rubal, María
AU  - Ramos Alonso, Eva
AU  - Calzaferri, Francesco
AU  - Zamorano-Fernández, Jorge
AU  - Giner-García, Javier
AU  - Palpán-Flores, Alexis J
AU  - Rodríguez-Domínguez, Víctor
AU  - Rodríguez de Cía, Javier
AU  - Hernández-García, Borja J
AU  - Romero Martínez, Manuel Alejandro
AU  - de Los Ríos, Cristóbal
AU  - Egea, Javier
PY  - 2025
DO  - 10.1111/bph.70108
SN  - 0007-1188
UR  - https://hdl.handle.net/20.500.14352/121900
T2  - British Journal of Pharmacology
AB  - Background and purpose:Traumatic brain injury (TBI) is considered to be a leading cause of mortality and disability worldwide. After TBI, innate immunity is rapidly activated in response to damage-associated molecular patterns, such as ATP release,...
LA  - eng
M2  - 1
PB  - Nature Publishing Group
KW  - Interleukin‐1 beta
KW  - Neuroinflammation
KW  - P2X7 receptor
KW  - Traumatic brain injury
TI  - Pharmacological evaluation of non-nucleotide purine derivatives as P2X7 antagonists for the treatment of neuroinflammation in traumatic brain injury.
TY  - journal article
ER  -